GSK Investigational Site

Observatory 7925

0 studies enrolling now · 7 studies all time

What they study most

Arthritis, Rheumatoid, Crohn's Disease, Diabetes Mellitus, Type 2, Influenza, Human, Nausea, Nausea and Vomiting, Chemotherapy-Induced, Vomiting

Studies at this site

• A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease — Completed
• Open-Label Extension Study of GSK1605786A — Stopped early
• GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease — Stopped early
• Thiazolidinedione Intervention With Vitamin D Evaluation — Stopped early
• Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital — Completed
• COX-2 Inhibitor Study In Patients With Rheumatoid Arthritis — Completed
• Intravenous And Oral Casopitant (GW679769) For The Prevention Of Chemotherapy Induced Nausea And Vomiting — Completed